Harrow Inc

자세한 내용은 Harrow Inc 회사

Harrow, Inc. is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the North American market. The Company offers a comprehensive portfolio of prescription and non-prescription pharmaceutical products. It owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in North America, all of which are marketed under the Harrow name. It owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical-compounding business. It owns United States commercial rights to various products: IHEEZO, VEVYE, TRIESENCE, VIGAMOX, ILEVRO, FLAREX, NATACYN, ZERVIATE, BYQLOVI and others. VIGAMOX (moxifloxacin hydrochloride ophthalmic solution) 0.5%, a fluoroquinolone antibiotic eye drops for the treatment of bacterial conjunctivitis caused by susceptible strains of organisms. IHEEZO (chloroprocaine hydrochloride ophthalmic gel) 3% is a low-viscosity gel indicated for ocular surface anesthesia.

회사 정보

종목 코드 HROW

회사 이름Harrow Inc

상장일Feb 08, 2013

설립일2006

CEOMr. John P. Saharek

직원 수382

유형Ordinary Share

회계 연도 종료Feb 08

주소1A Burton Hills Blvd

도시NASHVILLE

증권 거래소NASDAQ Global Market Consolidated

국가United States of America

우편 번호37215

전화16157334731

웹사이트https://www.harrow.com/

종목 코드 HROW

상장일Feb 08, 2013

설립일2006

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. Mark L. Baum, J.D.

Chairman of the Board, Chief Executive Officer

2.60M

+21.61%

Mr. Andrew R. Boll

Chief Financial Officer, Corporate Secretary

777.84K

+36.92%

Mr. John P. Saharek

President and Chief Executive Officer of ImprimisRx

467.39K

+58.62%

Dr. Adrienne L. Graves, Ph.D.

Independent Director

--

Mrs. Lauren P. Silvernail

Independent Director

--

Mr. Perry J. Sternberg

Lead Independent Director

--

Mr. Amir Shojaei, Ph.D.

Chief Scientific Officer

--

이름

이름/직위

직위

주식 보유

변동

Mr. Mark L. Baum, J.D.

Chairman of the Board, Chief Executive Officer

2.60M

+21.61%

Mr. Andrew R. Boll

Chief Financial Officer, Corporate Secretary

777.84K

+36.92%

Mr. John P. Saharek

President and Chief Executive Officer of ImprimisRx

467.39K

+58.62%

Dr. Adrienne L. Graves, Ph.D.

Independent Director

--

Mrs. Lauren P. Silvernail

Independent Director

--

Mr. Perry J. Sternberg

Lead Independent Director

--

수익 분석

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

사업별USD

이름

수익

비율

Product Sales Net

47.74M

0.00%

Transfer of acquired product sales/profit

86.00K

0.00%

데이터 없음

사업별

지역별

사업별USD

이름

수익

비율

Product Sales Net

47.74M

0.00%

Transfer of acquired product sales/profit

86.00K

0.00%

주식 보유 통계

마지막 업데이트: Fri, May 16

주주

주주 유형

주주

비율

Opaleye Management Inc.

10.72%

Baum (Mark L)

7.08%

BlackRock Institutional Trust Company, N.A.

6.20%

Private Capital Management

5.15%

The Vanguard Group, Inc.

5.07%

Other

65.78%

주주

비율

Opaleye Management Inc.

10.72%

Baum (Mark L)

7.08%

BlackRock Institutional Trust Company, N.A.

6.20%

Private Capital Management

5.15%

The Vanguard Group, Inc.

5.07%

Other

65.78%

주주 유형

주주

비율

Investment Advisor/Hedge Fund

23.15%

Hedge Fund

18.11%

Individual Investor

15.07%

Investment Advisor

12.93%

Research Firm

2.04%

Pension Fund

0.45%

Bank and Trust

0.33%

Sovereign Wealth Fund

0.07%

Insurance Company

0.03%

Other

27.83%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

340

26.58M

72.44%

-3.00M

2025Q1

354

25.78M

70.87%

-4.22M

2024Q4

350

26.13M

73.38%

-4.49M

2024Q3

325

25.90M

72.95%

-2.80M

2024Q2

296

24.70M

70.19%

-6.36M

2024Q1

284

26.34M

74.95%

-7.20M

2023Q4

279

28.26M

80.94%

-4.94M

2023Q3

275

28.51M

81.73%

-152.59K

2023Q2

265

25.64M

85.30%

+312.85K

2023Q1

246

23.86M

79.81%

+1.57M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

Opaleye Management Inc.

3.94M

10.72%

-4.80K

-0.12%

Jun 04, 2025

Baum (Mark L)

2.60M

7.08%

+461.94K

+21.61%

Apr 21, 2025

BlackRock Institutional Trust Company, N.A.

2.27M

6.2%

-1.07K

-0.05%

Mar 31, 2025

Private Capital Management

1.89M

5.15%

+195.64K

+11.54%

Mar 31, 2025

The Vanguard Group, Inc.

1.86M

5.07%

-6.65K

-0.36%

Mar 31, 2025

Kaufman (Daniel)

1.68M

4.59%

-222.91K

-11.69%

Aug 12, 2024

Braidwell LP

956.84K

2.61%

+49.80K

+5.49%

Mar 31, 2025

State Street Global Advisors (US)

786.48K

2.14%

-41.22K

-4.98%

Mar 31, 2025

Boll (Andrew R)

777.84K

2.12%

+209.75K

+36.92%

Apr 21, 2025

Geode Capital Management, L.L.C.

774.08K

2.11%

+52.97K

+7.35%

Mar 31, 2025

34.930USD

Harrow Inc

34.930

개요

회사

금융